Search
Displaying results 11 - 20 of 21 in total
Metastatic lung origin Progressive Neuroendocrine Tumors
go.drugbank.com/conditions/DBCOND0093547Drugs: EverolimusUnresectable gastrointestinal origin Progressive Neuroendocrine Tumors
go.drugbank.com/conditions/DBCOND0093543Drugs: EverolimusUnresectable lung origin Progressive Neuroendocrine Tumors
go.drugbank.com/conditions/DBCOND0093548Drugs: EverolimusVorsetuzumab mafodotin
go.drugbank.com/drugs/DB15352InvestigationalVorsetuzumab mafodotin is under investigation in clinical trial NCT01677390 (A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma).
Liver Transplant Rejection
go.drugbank.com/conditions/DBCOND0054228Refractory, advanced Breast cancer
go.drugbank.com/conditions/DBCOND0023190Lenvatinib
go.drugbank.com/drugs/DB09078ApprovedInvestigationalLenvatinib is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib also inhibits other RTKs that ...
Vinorelbine
go.drugbank.com/drugs/DB00361ApprovedInvestigationalVinorelbine is an anti-mitotic chemotherapy drug that is used in the treatment of several types of malignancies, including breast cancer and non-small cell lung cancer (NSCLC) . It was initially approved in the USA in 1990's for the trea...
Heart Transplant Rejection
go.drugbank.com/conditions/DBCOND0047700Kidney Transplant Rejection
go.drugbank.com/conditions/DBCOND0066662Drugs: Alemtuzumab · Antilymphocyte immunoglobulin (horse) · Azathioprine · Belatacept · Cyclosporine · Everolimus +2 more